Early Day Motion·EDM 1096

Medical Treatment of Kidney Patients

12 June 199069 Signatures

Motion Text

That this House notes that the drug Erythropoietin, EPO, that can greatly improve the lives of kidney patients may be denied to some of them because of financial pressures in the area in which they happen to live; and calls upon the Government to make a thorough assessment of the benefits of the drug and, if appropriate, to ensure that it is equally available to all kidney patients who would benefit from its use.